Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04

Go back to Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
(NASDAQ: ADIL) Delayed: 4.31 --0 (-0%)
Previous Close $4.31    52 Week High
Open $4.36    52 Week Low
Day High $4.49    P/E N/A 
Day Low $4.11    EPS
Volume 64,782